Janus kinase 2 - PDFSEARCH.IO - Document Search Engine

Janus kinase 2
Results: 27

#	Item
11	Translational initiation regulated by ATM in dendritic cells development Add to Reading List Source URL: www.nature.com Language: English - Date: 2014-09-11 08:37:09 Signal transduction Cytokines Growth factors Immunology AKT Mammalian target of rapamycin Phosphoinositide 3-kinase Ataxia telangiectasia Janus kinase 2 Biology Cell biology Cellular processes
12	Table 15.1 Myeloproliferative diseases and other myeloid neoplasms associated with point mutation or rearrangement of tyrosine kinase genes. Disease Add to Reading List Source URL: www.essentialhaematology6.com Language: English - Date: 2011-02-25 06:19:28 Hematopathology Cytokine receptors Polycythemia Myeloproliferative disease Syndromes Janus kinase 2 Myelodysplastic syndrome Erythropoietin receptor Chronic myelogenous leukemia Medicine Biology Tyrosine kinases
13	Combination therapy using JAK2 and HSP90 inhibitors increased efficacy in myelofibrosis in vivo Add to Reading List Source URL: medicalxpress.com Language: English - Date: 2015-03-04 03:17:09 Janus kinase inhibitor Hsp90 inhibitors Janus kinase 2 Hsp90 Myelofibrosis Heat shock protein Essential thrombocytosis Medicine Biology Ruxolitinib
14	Erythrocytosis Evaluation.indd Add to Reading List Source URL: www.mayomedicallaboratories.com Language: English - Date: 2014-11-06 13:03:55 Blood tests Hematopathology Hemoglobins Polycythemia Drugs in sport Janus kinase 2 Erythropoietin Hematocrit Myeloproliferative disease Medicine Biology Hematology
15	[removed] Objec.ves CH3 v  Deﬁne epigene.cs Add to Reading List Source URL: www.ascls.org Language: English - Date: 2014-10-21 17:36:38 Proteins Tyrosine kinases Molecular genetics EZH2 PRC2 DNA methyltransferase Janus kinase 2 Histone DNMT1 Biology Genetics Epigenetics
16	Beneficiary Full Name: ___________________________________________ Sponsor’s SSN: ______-_____-_______ Date of Birth: ____________________________________ Beneficiary State of Residence: _______________ Dear Provide Add to Reading List Source URL: www.hnfs.com Language: English - Date: 2015-01-04 19:30:12 Healthcare in the United States United States Department of Defense Myeloproliferative disease Janus kinase 2 Essential thrombocytosis Polycythemia vera Medical ethics TRICARE Janus kinase Medicine Tyrosine kinases Hematopathology
17	Beneficiary Full Name: ___________________________________________ Sponsor’s SSN: ______-_____-_______ Date of Birth: ____________________________________ Beneficiary State of Residence: _______________ Dear Provide Add to Reading List Source URL: www.hnfs.com Language: English - Date: 2015-01-05 01:57:08 United States Department of Defense Health Myeloproliferative disease TRICARE Medical ethics Thrombopoietin Janus kinase 2 Genetic testing Health Net Medicine Biology Healthcare in the United States
18	THE DRIVE TO DISCOVER. THE EXPERIENCE TO DELIVER. October 2014 www.incyte.com Add to Reading List Source URL: www.incyte.com Language: English - Date: 2014-10-13 15:47:24 Tyrosine kinases Ruxolitinib Myeloproliferative disease Myelofibrosis Essential thrombocytosis Polycythemia vera Thrombocytosis Splenomegaly Janus kinase 2 Medicine Oncology Hematopathology
19	1 Pharmacotherapy JAK inhibitors in myeloproliferative neoplasms Add to Reading List Source URL: www.mpnresearchfoundation.org Language: English - Date: 2011-09-13 08:25:55 Tyrosine kinases Signal transduction Pyrimidines Hematopathology Janus kinase inhibitor Janus kinase 2 Janus kinase Cytokine receptors Myeloproliferative disease Biology Medicine Cell signaling
20	Use of Molecular Testing to Identify a Cluster of Patients with Polycythemia Vera in Eastern Pennsylvania Add to Reading List Source URL: www.atsdr.cdc.gov Language: English - Date: 2011-09-27 10:28:27 Essential thrombocytosis Myeloproliferative disease Polycythemia Janus kinase 2 Thrombocytosis Myelofibrosis Splenomegaly Epidemiology of cancer Hematology Medicine Hematopathology Polycythemia vera